TY - JOUR
AU - A. J. Epstein
AU - C. L. Barry
AU - D. A. Fiellin
AU - S. H. Busch
A1 - 
AB - Most individuals with substance use disorders and with mental disorders do not receive treatment. If treatment options were more attractive, treatment rates might increase. The advantages of novel approaches, including primary care-based treatment and collaborative care in a primary care setting, have been documented. However, less is known about consumers' valuation of these options. The authors assessed monetary valuation of these treatment types compared with usual care in a specialty treatment setting. Contingent valuation methods were used in a Web-based randomized vignette experiment that involved 2,146 individuals who screened positive for a drug or alcohol use disorder or a mental disorder. Participants valued a primary care-based treatment visit over usual care in a specialty treatment setting by $9.00 and a collaborative care visit over usual care in a specialty treatment setting by $5.85.
BT - Psychiatric services (Washington, D.C.)
C5 - Financing & Sustainability
CP - 8
CY - United States
DO - 10.1176/appi.ps.201500077
IS - 8
JF - Psychiatric services (Washington, D.C.)
N2 - Most individuals with substance use disorders and with mental disorders do not receive treatment. If treatment options were more attractive, treatment rates might increase. The advantages of novel approaches, including primary care-based treatment and collaborative care in a primary care setting, have been documented. However, less is known about consumers' valuation of these options. The authors assessed monetary valuation of these treatment types compared with usual care in a specialty treatment setting. Contingent valuation methods were used in a Web-based randomized vignette experiment that involved 2,146 individuals who screened positive for a drug or alcohol use disorder or a mental disorder. Participants valued a primary care-based treatment visit over usual care in a specialty treatment setting by $9.00 and a collaborative care visit over usual care in a specialty treatment setting by $5.85.
PP - United States
PY - 2015
SN - 1557-9700; 1075-2730
SP - 772
EP - 774
EP - 
T1 - Consumers' Valuation of Primary Care-Based Treatment Options for Mental and Substance Use Disorders
T2 - Psychiatric services (Washington, D.C.)
TI - Consumers' Valuation of Primary Care-Based Treatment Options for Mental and Substance Use Disorders
U1 - Financing & Sustainability
U2 - 25930049
U3 - 10.1176/appi.ps.201500077
VL - 66
VO - 1557-9700; 1075-2730
Y1 - 2015
ER -